Pulmonary sequestration presented as massive left hemothorax and associated with primary lung sarcoma by Vincenzo Di Crescenzo et al.
RESEARCH ARTICLE Open Access
Pulmonary sequestration presented as massive
left hemothorax and associated with primary
lung sarcoma
Vincenzo Di Crescenzo1*, Paolo Laperuta1, Filomena Napolitano1, Chiara Carlomagno2, Alfredo Garzi1, Mario Vitale1
From 26th National Congress of the Italian Society of Geriatric Surgery
Naples, Italy. 19-22 June 2013
Abstract
Pulmonary sequestration is an uncommon disease, accounting for only approximately 1.5% of all congenital
pulmonary malformations. In most cases, the diagnosis is a result of accidental radiological findings; it is rarely
accompanied by clinical symptoms, and is more commonly associated with other congenital malformations. Herein,
we reported a case of pulmonary sequestration presented as massive left hemothorax and associated with primary
lung sarcoma. A pneumonectomy via thoracotomy was attended with complete resection of sequestration and of
sarcoma. The postoperative course was unremarkable, and the patient was discharged on postoperative day 11.
Backgroud
Pulmonary sequestration is an uncommon disease,
accounting for only approximately 1.5% of all congenital
pulmonary malformations [1-3]. In most cases, the diag-
nosis is a result of accidental radiological findings; it is
rarely accompanied by clinical symptoms, and is more
commonly associated with other congenital malforma-
tions. In the present case pulmonary sequestration pre-
sented as massive left hemothorax was associated with
primary lung sarcoma. A pneumonectomy via thoracot-
omy was attended with complete resection of sequestra-
tion and of sarcoma.
Case presentation
A 35 years-old woman was admitted to local hospital
complained of dyspnea, cough and hemoptosis. A Chest
X-ray showed the presence of massive left pleural effu-
sion. Thus, she referred to our unit for the treatment. A
chest computed tomography (CT) scan confirmed the
presence of pleural effusion accompanied by an area of
consolidation. Pleural puncture undoubtedly revealed
hemothorax. A tube thoracostomy yielded hemothorax
to the amount of 1100 ml. The clinical condition of
patients was stable and all laboratory values were within
normal. A repeated CT scan performed three days after
the procedure, confirmed the presence of area of conso-
lidation in lower left lobe and the presence of an hilar
nodule (size 3 mm) not been reported before (Figure 1).
Bronchoscopy showed no endoluminal lesion and the
pathological results from bronchoalveolar lavage showed
the presence of inflammatory cells in absence of malig-
nant cells [4,5]. Then a fine needle biopsy CT-guided
was attended but the results was inconclusive for a defi-
nitive diagnosis. Arteriography diagnosed the mass
located in lower lobe to be a sequestration. Thus, our
strategy was to attend an exploratory thoracotomy. The
sequestration was successfully resected with partial
resection of the diaphragm. Then the nodule was biop-
sied and the intraoperative diagnosis was positive for
malignancy, possibly a sarcoma, whereas a conclusive
diagnosis on frozen sections specimen was not possible.
The tumor invaded the main trunk of left pulmonary
artery, thus contraindicated a bronchoplastic procedure.
A pneumonectomy was attended in a standard manner.
A chest drainage was left in the chest, and removed two
days after. For postoperative pain control, a patient con-
trolled analgesia was used for the first two days [6].
Pathologic examinations revealed the sequestration to
be an infarcted extralobar sequestration (ELS). Small
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elastic arteries were identified within the sequestration.
The final diagnosis of the tumor was primary fibrosar-
coma of the lung according to the pathological and
immunostaining results as reported in Figures 2. And 3.
The postoperative course was unremarkable, and the
patient was discharged on postoperative day 11.
Discussion
Pulmonary sequestration is defined as a mass of nonfunc-
tioning lung tissue that receives blood supply from an
anomalous systemic artery and does not communicate
with the normal bronchial tree, being divided into two
forms: intralobar sequestration (ILS) and extralobar
sequestration (ELS) [1-3] Whereas ELS is enclosed within
its own pleural membrane, ILS shares the pleural mem-
brane of the normal lung. Considered a congenital dis-
ease, ELS results from an accessory lung bud that, in
some cases, maintains the original connection with the
intestine, allowing communication between the sequestra-
tion and the gastrointestinal tract. The arterial blood sup-
ply to the sequestered lung by aberrant elastic arteries
mostly originates from the thoracic or abdominal aorta in
most cases with EPS. These arteries may arise above or
below the diaphragm, and are usually small and variable
[1]. The left hemithorax is the most commonly affected
(in 65% of cases), and the primary site of ELS is the
region between the lower lung lobe and the diaphragm
(in 63%), as in the present case. In more than 60% of all
cases of ELS, other congenital anomalies coexist, the
most common of which is diaphragmatic hernia (in 16%).
In approximately 25% of the cases, another pulmonary
abnormality, such as pulmonary hypoplasia, cystic adeno-
matoid malformation or congenital lobar emphysema, is
also present [2]. The treatment for pulmonary sequestra-
tion is surgery. In the case of ELS, sequestrectomy should
be performed. The identification and control of the
Figure 1
Figure 2 Histological features of the primary pulmonary
fibrosarcoma showing a momorphous population of small and
undifferentiated spindle cells (Haematoxylin Eosin 430X).
Figure 3 Immunohistochemical features of the primary
pulmonary fibrosarcoma showing diffuse positivity for
Vimentin (APAAP 430X).
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aberrant artery branch, above or below the diaphragm,
are essential for preventing hemorrhage. Postoperative
results are typically excellent [3].
Among the previous reports detected by PubMed using
key words for symptomatic EPS such as hemothorax,
infarction or torsion, only few cases with symptomatic
EPS were cited. The symptoms of these cases were ipsi-
lateral chest pain and respiratory failure with sudden
onset caused by hemothorax and infarction. The location
of the EPS was the left costovertebral angle adjacent to
the inferior ligament in all patients. Based on these pre-
vious reports and our experience, symptomatic EPS may
be related to infarction caused by torsion under exposure
to drastic pleural cavity movement or by infection asso-
ciated with bacteremia [2]. Conversely, we did not find in
literature any paper in which the concomitant presence
of pulmonary sequestration and primary lung sarcoma
was described. Primary sarcoma of the lung is a rare
tumor [7]. In general, sarcomas disseminate by the hema-
togenous route; consequently, metastases are found fre-
quently in the lungs. Therefore, in any case of pulmonary
sarcoma, a total body survey is necessary to exclude a
primary tumor elsewhere. That because primary pulmon-
ary sarcomas must be distinguished from the more fre-
quent occurrence of sarcoma metastatic to the lung,
primary pulmonary sarcomatoid carcinoma, and diffuse
malignant mesothelioma involving the lung. Diagnosis of
primary pulmonary sarcoma is not easy without thoracot-
omy. There are no specific presenting symptoms, and
roentgenologic manifestations were not characteristic. It
is difficult, if not impossible, to get a correct diagnosis of
a malignant mesenchymal tumor from cytologic examina-
tion of a (needle) aspirate. Tumor biopsy is necessary to
get a diagnosis, and tumor tissue was obtained only
before thoracotomy in case of endoluminal growth of a
tumor. During the operation, the malignant mesenchymal
nature of the tumor may not become clear on macro-
scopic appearance [8]. It may be helpful to take a biopsy
specimen for histologic examination of a frozen section
specimen. Once the diagnose has been established (dur-
ing operation) radical resection appears to be the only
treatment with good prognosis. Sometimes, the final diag-
nosis is obtained postoperative after complete resection of
the tumor as in the present case. That because the
availability of multiple cytokeratin antibody tests has
improved the identification of sarcomatoid carcinomas
and diffuse malignant mesothelioma. The introduction of
CD34 has facilitated the recognition of both benign and
malignant intrathoracic, fibrous tumors [9-16]. Finally, we
reported an exceptional case of ELS associated with pri-
mary sarcoma of the lung, not been reported in literature
before. Both lesions were successfully removed with a left
penumonectomy. In case of hemothorax and the pre-
sence of multiple lesions (as the present case), a surgical
exploration via thoracotomy is required in order to
remove all lesions and obtain a definitive diagnosis.
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